Advertisement
The interview will cover topics including Osteologix's market potential,growth initiatives, competitive positioning, recent news, and milestones forwhich investors should watch.
Advertisement
To hear the interview in its entirety, visit http://www.wallst.net, andclick on "Interviews." The interview can be accessed either by locating thecompany's ticker symbol under the appropriate exchange at the top of the"Interviews" section of the site, or by entering the company's ticker symbolin the Search Archive window on the right-hand column of the "Interviews"section once it is posted.
About Osteologix:
Osteologix develops pharmaceutical products for bone and cartilagedisorders addressing large markets and offering low-risk development. Thetherapies developed by Osteologix represent valuable solutions to the patientssuffering from diseases of bone and cartilage, and they representcost-effective therapeutic options for the healthcare providers. Osteologix isdeveloping NB S101, a once daily tablet containing strontium malonate, as atreatment for osteoporosis. The phase II study evaluating NB S101 is arandomized, double-blind, placebo-controlled, parallel-group efficacy andsafety trial with the objective of assessing the effects of NB S101 on bonemetabolism while also evaluating its safety, tolerability and pharmacokineticsin postmenopausal women. In addition to the primary endpoint of boneresorption, the company is evaluating the effects of NB S101 on bone formationand bone mineral density.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a whollyowned subsidiary of Financial Media Group, Inc.(http://www.financialmediagroupinc.com). The Web site is a leading provider oftimely business news, executive interviews, multimedia content, and researchtools. Financial Media Group, Inc. also owns http://www.mywallst.net, afinancial social network for investors, and Financial Filings Corp.(http://www.financialfilings.com), a provider of media and compliancesolutions to publicly traded companies. In addition to WallSt.net, WallStreetDirect, Inc. owns and operates WallStRadio (http://www.wallstradio.com), abusiness and finance podcast Web site. Financial Filings Corp. is expecting toreceive two hundred eighty dollars from Osteologix, Inc. for the disseminationof this press release. For a complete list of our advertisers, and advertisingrelationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO) Contact: WallSt.net 800-4-WALL-ST
SOURCE Financial Filings Corp.
